Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Emerging Gene Manipulation Strategies for the Treatment of Monogenic Eye Disease.

Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) - 1 Jan 2000

Burgess Frederick R, Hall Hildegard Nikki, Megaw Roly

Abstract excerpt

Genetic eye diseases, representing a wide spectrum of simple and complex conditions, are one of the leading causes of visual loss in children and working adults, and progress in the field has led to changes in disease investigation, diagnosis, and management. The past 15 years have seen the emergence of novel therapies for these previously untreatable conditions to the extent that we now have a licensed therapy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Child
Share to cis-trans-Isomerases
Share to Dependovirus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Eye Diseases

Share to Genetic Therapy

Share to Genetic Vectors

Share to Leber Congenital Amaurosis

Share to Mutation

Source

Identifiers

PMID: 36041151
DOI: 10.1097/APO.0000000000000545

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Emerging Gene Manipulation Strategies for the Treatment of Monogenic Eye Disease.PMID 36041151Read ↗

Gene Therapy for Inherited Retinal Diseases: From Laboratory Bench to Patient Bedside and BeyondSemantic proximity Read ↗

Gene therapy for inherited retinal diseases: progress and possibilitiesSemantic proximity Read ↗

The Role of Gene Therapy in the Treatment of Retinal Diseases: A ReviewSemantic proximity Read ↗

Voretigene Neparvovec and Gene Therapy for Leber’s Congenital Amaurosis: Review of Evidence to DateSemantic proximity Read ↗

Insights into eye genetics and recent advances in ocular gene therapySemantic proximity Read ↗

Retinal gene therapySemantic proximity Read ↗

Gene-Based Therapeutics for Acquired Retinal Disease: Opportunities and ProgressSemantic proximity Read ↗

Gene therapy strategies in ophthalmology—an overview of current developments and future prospectsSemantic proximity Read ↗

Gene therapy for inherited retinal diseasesSemantic proximity Read ↗

An Update on Gene Therapy for Inherited Retinal Dystrophy: Experience in Leber Congenital Amaurosis Clinical Trials.Semantic proximity Read ↗

Gene therapy and the adeno‐associated virus in the treatment of genetic and acquired ophthalmic diseases in humans: Trials, future directions and safety considerationsSemantic proximity Read ↗

Advances in Precision Therapeutics and Gene Therapy Applications for Retinal Diseases: Impact and Future DirectionsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.